Bleichroeder Acquisition Corp. III (to be renamed Inflection Point Mach X Bleichroeder Corp., symbol BCCQ) is pursuing a business combination with Ursa Major Technologies, Inc. that would take Ursa Major public on Nasdaq under the ticker IPXX, with completion targeted in the first quarter of 2027. Ursa Major develops hypersonic missile systems, solid rocket motors and in-space propulsion, aiming to address U.S. gaps in hypersonics, critical munitions capacity and modern manufacturing. The company reports 2024 revenue of $18.5 million, 2025 revenue of $45 million and a 2026 revenue expectation of $100 million, tied to U.S. Navy, Air Force and prime-contractor programs. Management cites a near-term pipeline of about $2.8 billion and a 2027 revenue target of approximately $200 million, supported by hypersonic “Havoc” missiles and the “Lynx” solid rocket motor production system. Proceeds from the transaction are intended to expand production infrastructure, including facilities capable of over 1 million pounds of energetics annually and scaling Havoc output from about 8 to 500 units per year. The communication also outlines forthcoming SEC filings on Form S-4 and extensive risk factors related to completing the deal and executing Ursa Major’s growth plan.
Bleichroeder Acquisition Corp. III (BCCQ), a SPAC to be renamed Inflection Point Mach X Bleichroeder (Nasdaq: IPXX), entered into a definitive business combination agreement with Ursa Major Technologies, Inc., a hypersonics and solid rocket motor manufacturer. The combination is expected to provide at least $350 million in committed capital to scale Ursa Major’s defense industrial production, with the combined company anticipated to trade on Nasdaq in the first quarter of 2027.
Ursa Major has previously raised approximately $380 million privately, conducted more than 5,500 ground tests and 140,000 seconds of testing, and its engines have powered more than a dozen hypersonic missions. Near-term proceeds are expected to expand operations at Galeton, Colorado into a large-scale solid rocket motor production campus and support liquid engine, additive manufacturing, and all-up-round development.
Bleichroeder Acquisition Corp. III (to be renamed Inflection Point Mach X Bleichroeder Corp., symbol BCCQ) announced a planned business combination with Ursa Major Technologies, Inc. via a de-SPAC merger. The transaction is anticipated to bring $350 million of capital into Ursa Major, including approximately $110 million shortly after signing of the Business Combination Agreement and the remainder at closing, when Ursa Major is expected to become publicly traded.
The deal values Ursa Major at a $1.6 billion pre-money valuation and $2.3 billion post-money, compared with a reported prior round valuation of $600 million in late 2025. Closing of the de-SPAC transaction is currently anticipated in the first quarter of 2027, subject to customary conditions, shareholder approvals and SEC review of a planned Registration Statement on Form S-4 that will include a proxy statement/prospectus for Mach X shareholders.
Bleichroeder Acquisition Corp. III (BCCQ), which will be renamed Inflection Point Mach X Bleichroeder Corp. and domesticated into Delaware, announced a planned business combination with Ursa Major Technologies, Inc. through a de-SPAC merger. The parties currently expect the transaction to provide at least $350 million in committed capital and to value Ursa Major at $2.3 billion post-money. At closing, Ursa Major is expected to become a publicly traded company listed on Nasdaq, with closing targeted for the first quarter of 2027, subject to shareholder approvals, regulatory conditions, financing and other customary closing conditions. Mach X intends to file a Registration Statement on Form S-4 with the SEC, including a proxy statement/prospectus for Mach X shareholders regarding the vote on the Business Combination.
Bleichroeder Acquisition Corp. III (BCCQ) entered into a Business Combination Agreement to merge its wholly owned Merger Sub with Ursa Major Technologies, Inc., with Ursa Major becoming a wholly owned subsidiary after closing. Before closing, BCCQ will complete a Domestication from Cayman Islands to Delaware and be renamed by mutual agreement with Ursa Major.
The merger values Ursa Major at a $1,600,000,000 Purchase Price, payable in an aggregate of 160,000,000 shares of common stock at $10.00 per share equivalent, with separate consideration structures for common, preferred and pre-funded securities. Closing is conditioned on shareholder approvals, effectiveness of a Form S-4, Nasdaq listing, HSR clearance and a Minimum Cash Condition of at least $150,000,000, which Ursa Major may waive.
Concurrently, BCCQ arranged a $242.5 million Series A preferred stock PIPE (10.0% cumulative convertible preferred plus matching warrants) and Ursa Major completed a $107.5 million pre-funded PIPE. New governance, lock-up, support and registration rights agreements, as well as protective provisions and dividend, conversion, put and call terms for the Series A preferred, will govern the post‑combination capital structure.
Bleichroeder Acquisition Corp. III (symbol: BCCQ) is the issuer of record for a Form 8-K filing submitted to the SEC.
Bleichroeder Acquisition Corp. III is a Cayman Islands special purpose acquisition company formed on April 1, 2026 to complete a Business Combination. For the period from inception through June 30, 2026, it had no operating revenues and reported a net loss of $2,078,048, driven by $62,298 of formation, general and administrative costs and $2,015,750 of share-based compensation to officers. At June 30, 2026, total assets were $512,356, mainly deferred offering costs, against current liabilities of $549,654, resulting in a shareholders’ deficit of $37,298 and a working capital deficit of $527,974.
Subsequent to quarter-end, on July 8, 2026 the company completed its IPO of 34,500,000 units at $10.00 per unit, including full over-allotment, generating $345,000,000 of gross proceeds, and sold 8,500,000 Private Placement Warrants for an additional $8,500,000. An aggregate $345,000,000 was placed in a Trust Account at $10.00 per public share, while transaction costs totaled $21,364,856. The SPAC has 24 months from the IPO closing (the “Completion Window”) to consummate a Business Combination and may use up to $2,000,000 in convertible Working Capital Loans if needed.